Effect of different UCOE-promoter combinations in creation of engineered cell lines for the production of Factor VIII
2011

Effect of UCOE-Promoter Combinations on Factor VIII Production

Sample size: 14 publication Evidence: moderate

Author Information

Author(s): Nair Ayyappan R, Jinger Xie, Hermiston Terry W

Primary Institution: US Innovation Center, Bayer Healthcare

Hypothesis

Different UCOE-promoter combinations will affect the expression levels of BDD-FVIII in engineered cell lines.

Conclusion

Certain UCOE-promoter combinations are more effective than others in expressing the BDD-FVIII protein in BHK21 cells.

Supporting Evidence

  • The 1.5 Kb human RNP UCOE outperformed the 3.2 Kb mouse RPS3 UCOE in expressing BDD-FVIII.
  • Expression levels driven by several promoters were equal to or better than the human CMV promoter.
  • The study demonstrated that the 1.5 Kb UCOE is a better choice for stable expression of BDD-FVIII.

Takeaway

This study tested different combinations of UCOE and promoters to see which ones help make a protein better in cells, and found that some combinations work much better than others.

Methodology

The study involved transient transfection of 14 different UCOE-promoter combinations into BHK21 cells and measuring the expression of BDD-FVIII.

Limitations

The study primarily focused on two UCOE fragments and may not encompass all possible combinations or cell types.

Statistical Information

P-Value

p<0.01

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1756-0500-4-178

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication